JPRN-UMIN000024992已完成2 期
Phase 2 study of dose dense AC and dose dense PTX as perioperative chemotherapy for patients with HER2 negative breast cancer(WJOG9016B) - Phase 2 study of dose dense AC and dose dense PTX as perioperative chemotherapy for patients with HER2 negative breast cancer(WJOG9016B)
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 入组人数
- 90
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 65years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) Active double cancer 2) Active infection 3) Lactating, pregnant, or not willing to contraception women 4) Mental disorders 5) On steroids or immune suppressants 6) History of severe hypersensitivity 7) History of severe complication 8) Judged as inappropriate to be included study by treating physician
研究者
相似试验
已完成
不适用
Phase2 study of dose dense EC followed Nab-PTXas neoadjuvant chemotherapy for HER2-negative primary breast cancerbreast cancerJPRN-UMIN000020693Kyoto Prefectural University of Medicine50
已完成
2 期
Feasibility Phase 2 study of Dose-dense AC or EC followed by PTX for operable breast cancerbreast cancerJPRN-UMIN000022097PO Setouchi Breast Project50
进行中（未招募）
2 期
Phase II study of R-CHOP and R-high-dose MTX therapy for IVLBCJPRN-jRCTs041180165Yamaguchi Motoko37
招募中
不适用
Phase II study of dose escalation and concentration in stereotactic body radiotherapy (SBRT) for metastatic pulmonary or liver tumors from colorectal cancerJPRN-UMIN000026577Ofuna Chuo Hospital23
进行中（未招募）
1 期
Radiodynamic therapy (RDT) with Gliolan in patients with first recurrence of brain tumorrecurrence of glioblastomaMedDRA version: 20.0Level: PTClassification code 10018336Term: GlioblastomaSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2021-004631-92-DEWestfälische Wilhelms-Universität Münster, C/o Universitätsklinikum Münster Geschäftsbereich Recht u. Drittmittel33